Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Heidegger

Showing results (61-70 of 155) with videos related to

Pageof 16
Sort By:
European Urology Oncology|July 26, 2021
Intermediate-risk Prostate Cancer-A Sheep in Wolf's Clothing?Isabel Heidegger, Freddie C Hamdy, Roderick C N van den Bergh, et al.
Molecular Endocrinology (Baltimore, Md.)|October 10, 2015
Both IGF1R and INSR Knockdown Exert Antitumorigenic Effects in Prostate Cancer In Vitro and In VivoPhilipp Ofer, Isabel Heidegger, Iris E Eder, et al.
Clinical Genitourinary Cancer|July 2, 2018
Prognostic Value of Testing PD-L1 Expression After Radical Cystectomy in High-risk PatientsRenate Pichler, Josef Fritz, Felizian Lackner, et al.
World Journal of Urology|October 23, 2013
Is real-time PCR the correct method to evaluate the incidence of human papillomavirus in prepuces of asymptomatic boys and men?Isabel Heidegger, Renate Pichler, Barbara Müller, et al.
World Journal of Urology|December 15, 2018
Predictors of thrombosis in testicular cancer during platinum-based chemotherapyPia Paffenholz, Katharina Grein, Isabel Heidegger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 20, 2016
Detection of recurrent prostate cancer lesions before salvage lymphadenectomy is more accurate with (68)Ga-PSMA-HBED-CC than with (18)F-Fluoroethylcholine PET/CTDavid Pfister, Daniel Porres, Axel Heidenreich, et al.
The Prostate|August 27, 2015
Is Eotaxin-1 a serum and urinary biomarker for prostate cancer detection and recurrence?Isabel Heidegger, Julia Höfer, Markus Luger, et al.
The American Journal of Pathology|October 11, 2011
Expression of the IGF axis is decreased in local prostate cancer but enhanced after benign prostate epithelial differentiation and TGF-β treatmentPetra Massoner, Michael Ladurner Rennau, Isabel Heidegger, et al.
Diagnostics (Basel, Switzerland)|August 26, 2022
Challenges in Diagnosis of Uretero-Arterial Fistulas after Complex Pelvic Oncological Procedures-Single Center Experience and Review of the LiteratureCristian Surcel, Cristian Mirvald, Robert Stoica, et al.
Oncotarget|August 4, 2016
Critical role of androgen receptor level in prostate cancer cell resistance to new generation antiandrogen enzalutamideJulia Hoefer, Mohammady Akbor, Florian Handle, et al.
Pageof 16

Showing results (61-70 of 155) with videos related to

Sort By:
Pageof 16
European Urology Oncology|July 26, 2021
Intermediate-risk Prostate Cancer-A Sheep in Wolf's Clothing?Isabel Heidegger, Freddie C Hamdy, Roderick C N van den Bergh, et al.
Molecular Endocrinology (Baltimore, Md.)|October 10, 2015
Both IGF1R and INSR Knockdown Exert Antitumorigenic Effects in Prostate Cancer In Vitro and In VivoPhilipp Ofer, Isabel Heidegger, Iris E Eder, et al.
Clinical Genitourinary Cancer|July 2, 2018
Prognostic Value of Testing PD-L1 Expression After Radical Cystectomy in High-risk PatientsRenate Pichler, Josef Fritz, Felizian Lackner, et al.
World Journal of Urology|October 23, 2013
Is real-time PCR the correct method to evaluate the incidence of human papillomavirus in prepuces of asymptomatic boys and men?Isabel Heidegger, Renate Pichler, Barbara Müller, et al.
World Journal of Urology|December 15, 2018
Predictors of thrombosis in testicular cancer during platinum-based chemotherapyPia Paffenholz, Katharina Grein, Isabel Heidegger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 20, 2016
Detection of recurrent prostate cancer lesions before salvage lymphadenectomy is more accurate with (68)Ga-PSMA-HBED-CC than with (18)F-Fluoroethylcholine PET/CTDavid Pfister, Daniel Porres, Axel Heidenreich, et al.
The Prostate|August 27, 2015
Is Eotaxin-1 a serum and urinary biomarker for prostate cancer detection and recurrence?Isabel Heidegger, Julia Höfer, Markus Luger, et al.
The American Journal of Pathology|October 11, 2011
Expression of the IGF axis is decreased in local prostate cancer but enhanced after benign prostate epithelial differentiation and TGF-β treatmentPetra Massoner, Michael Ladurner Rennau, Isabel Heidegger, et al.
Diagnostics (Basel, Switzerland)|August 26, 2022
Challenges in Diagnosis of Uretero-Arterial Fistulas after Complex Pelvic Oncological Procedures-Single Center Experience and Review of the LiteratureCristian Surcel, Cristian Mirvald, Robert Stoica, et al.
Oncotarget|August 4, 2016
Critical role of androgen receptor level in prostate cancer cell resistance to new generation antiandrogen enzalutamideJulia Hoefer, Mohammady Akbor, Florian Handle, et al.
Pageof 16